Browsing Tag
Bain Capital
39 posts
Bain Capital takes control of FineToday Holdings in private equity-to-PE deal
Bain Capital acquires FineToday from CVC Capital Partners, signaling a new chapter for the Japan-based personal care brand. Find out what this deal means.
Why Bain Capital is betting $344m on this Korean yoga wear brand’s global rise
Bain Capital acquires Korean athleisure brand Andar for $344M. Find out why this deal signals private equity’s next move in wellness fashion.
Bain Capital’s $400m SPAC IPO: Why $10 pricing could define its investor appeal in 2025
Bain Capital’s $400M SPAC IPO at $10 per unit sets a cautious but confident tone for 2025. Explore structure, risks, and investor sentiment now.
Inside CapVest’s acquisition of STADA: What changes after Bain Capital and Cinven?
CapVest is acquiring majority control of STADA from Bain and Cinven. Find out how this move could reshape the pharma giant’s global growth strategy.
Why private equity interest in UK mid-cap takeovers is fading after GlobalData and Craneware
Private equity bids for GlobalData, Craneware, and Darktrace failed amid governance pushback. See why UK mid-cap dealmaking is shifting in 2025.
Redwire (NYSE: RDW) stock gains as Edge Autonomy merger adds $100m seller note and fresh debt
Redwire amends $925M Edge Autonomy merger with seller note and fresh debt. Stock trades near $20 amid strong institutional backing. Read full analysis.
Craneware plc surges as Bain Capital explores potential takeover
Craneware stock jumps 7.8% as Bain Capital explores a possible acquisition. Explore deal details, investor sentiment, and shareholding analysis before June 13.
Bain Capital moves to secure joint control in Manappuram Finance with strategic investment
Discover how Bain Capital’s ₹4,385 crore investment is set to reshape Manappuram Finance’s future in India’s financial services sector.
Digital Media Solutions completes investor-led acquisition, strengthening financial position for future growth
Digital Media Solutions, Inc. has completed the sale of its core assets to a consortium of leading investment…
Bain Capital’s $3.3bn acquisition of Mitsubishi Tanabe Pharma aims to reshape Japan’s pharmaceutical landscape
Bain Capital, a prominent global private investment firm, has announced a definitive agreement to acquire Mitsubishi Tanabe Pharma…